Meade Medaugh, P.E.

Transitioning an AAV gene therapy program from adherent cell culture to a suspension platform is

    Grant Writing · Pharma & Drug Development · Complete Guide The Complete Guide

BOSTON, MA — May 6, 2026 — DES Pharma, a premier provider of strategic advisory

The countdown has officially begun. From May 11–14, 2026, the global biopharmaceutical community will descend

Biotech is the rare industry where a single decision — a missed FDA meeting, a

The pharmaceutical landscape is evolving rapidly, and staying ahead of the curve means keeping a

The field of genetic and cellular medicines is advancing at an unprecedented pace, and there

FOR IMMEDIATE RELEASE DES Pharma to Attend DCAT Week 2026 in New York City Engineering Confidence in

The pharmaceutical landscape is shifting beneath our feet. As the industry prepares for DCAT Week

As we look toward the 2026 regulatory horizon, the European landscape is undergoing its most